BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1730007)

  • 1. Effect of Ca2+ ions on the slow active/inactive transition of the mitochondrial NADH-ubiquinone reductase.
    Kotlyar AB; Sled VD; Vinogradov AD
    Biochim Biophys Acta; 1992 Jan; 1098(2):144-50. PubMed ID: 1730007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow active/inactive transition of the mitochondrial NADH-ubiquinone reductase.
    Kotlyar AB; Vinogradov AD
    Biochim Biophys Acta; 1990 Aug; 1019(2):151-8. PubMed ID: 2119805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the mitochondrial NADH-ubiquinone reductase with rotenone as related to the enzyme active/inactive transition.
    Grivennikova VG; Maklashina EO; Gavrikova EV; Vinogradov AD
    Biochim Biophys Acta; 1997 Apr; 1319(2-3):223-32. PubMed ID: 9131045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H+/2e- stoichiometry of the nadh:ubiquinone reductase reaction catalyzed by submitochondrial particles.
    Galkin AS; Grivennikova VG; Vinogradov AD
    Biochemistry (Mosc); 2001 Apr; 66(4):435-43. PubMed ID: 11403652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic activity of NADH-ubiquinone oxidoreductase (complex I) in intact mitochondria. evidence for the slow active/inactive transition.
    Grivennikova VG; Kapustin AN; Vinogradov AD
    J Biol Chem; 2001 Mar; 276(12):9038-44. PubMed ID: 11124957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transition between active and de-activated forms of NADH:ubiquinone oxidoreductase (Complex I) in the mitochondrial membrane of Neurospora crassa.
    Grivennikova VG; Serebryanaya DV; Isakova EP; Belozerskaya TA; Vinogradov AD
    Biochem J; 2003 Feb; 369(Pt 3):619-26. PubMed ID: 12379145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hysteresis behavior of complex I from bovine heart mitochondria: kinetic and thermodynamic parameters of retarded reverse transition from the inactive to active state].
    Maklashina EO; Sled' VD; Vinogradov AD
    Biokhimiia; 1994 Jul; 59(7):946-57. PubMed ID: 7948420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH-ubiquinone reductase preparation.
    Takeshige K; Minakami S
    Biochem J; 1979 Apr; 180(1):129-35. PubMed ID: 39543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mitochondrial and Paracoccus denitrificans NADH-ubiquinone reductase by oxacarbocyanine dyes. A structure-activity study.
    Anderson WM; Wood JM; Anderson AC
    Biochem Pharmacol; 1993 May; 45(10):2115-22. PubMed ID: 8512593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of metal ions on mitochondrial pyridine dinucleotide transhydrogenase.
    O'Neal SG; Earle SR; Fisher RR
    Biochim Biophys Acta; 1980 Feb; 589(2):217-30. PubMed ID: 7356984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Participation of the quinone acceptor in the transition of complex I from an inactive to active state].
    Maklashina EO; Vinogradov AD
    Biokhimiia; 1994 Nov; 59(11):1638-45. PubMed ID: 7873673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the inhibitory action of natural rotenone and its stereoisomers with various NADH-ubiquinone reductases.
    Ueno H; Miyoshi H; Ebisui K; Iwamura H
    Eur J Biochem; 1994 Oct; 225(1):411-7. PubMed ID: 7925463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation of complex I in the reaction of NADH oxidation and delta mu H+-dependent NAD+ reduction by succinate].
    Kotliar AB
    Biokhimiia; 1990 Feb; 55(2):195-200. PubMed ID: 2111181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triton X-100 as a specific inhibitor of the mammalian NADH-ubiquinone oxidoreductase (Complex I).
    Ushakova AV; Grivennikova VG; Ohnishi T; Vinogradov AD
    Biochim Biophys Acta; 1999 Jan; 1409(3):143-53. PubMed ID: 9878712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of mitochondrial NADH-ubiquinone reductase (Complex I) by an alkyl polyoxyethylene ether.
    Suzuki H; Wakai M; Ozawa T
    Biochem Int; 1986 Aug; 13(2):351-7. PubMed ID: 3094534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active/de-active state transition of the mitochondrial complex I as revealed by specific sulfhydryl group labeling.
    Gavrikova EV; Vinogradov AD
    FEBS Lett; 1999 Jul; 455(1-2):36-40. PubMed ID: 10428467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A competitive inhibition of the mitochondrial NADH-ubiquinone oxidoreductase (complex I) by ADP-ribose.
    Zharova TV; Vinogradov AD
    Biochim Biophys Acta; 1997 Jul; 1320(3):256-64. PubMed ID: 9230920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-dependent change of nucleotide affinity to the active site of the mammalian complex I.
    Grivennikova VG; Kotlyar AB; Karliner JS; Cecchini G; Vinogradov AD
    Biochemistry; 2007 Sep; 46(38):10971-8. PubMed ID: 17760425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcium ions and inhibitors on internal NAD(P)H dehydrogenases in plant mitochondria.
    Rasmusson AG; Møller IM
    Eur J Biochem; 1991 Dec; 202(2):617-23. PubMed ID: 1722151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the proton-translocating NADH:ubiquinone oxidoreductases of mitochondria and Escherichia coli using the inhibitor 1,10-phenanthroline.
    Finel M; Majander A
    FEBS Lett; 1994 Feb; 339(1-2):142-6. PubMed ID: 8313963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.